Calithera Biosciences (NASDAQ:CALA) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report issued on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of NASDAQ:CALA opened at $0.01 on Friday. Calithera Biosciences has a 1-year low of $0.00 and a 1-year high of $0.12. The firm has a fifty day moving average price of $0.01 and a 200 day moving average price of $0.02.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.